References

Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach

10.1016/s2213-2600(18)30043-2 · 2018 · External reference

Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series

10.1183/13993003.01369-2016 · 2017 · External reference

Alveolar lipoproteinosis in lung allograft recipients

10.1016/s0046-8177(97)90228-8 · 1997 · External reference

Long-term persistence of human donor alveolar macrophages in lung transplant recipients

10.1136/thoraxjnl-2016-208292 · 2016 · External reference

Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case

10.21037/jtd.2018.04.49 · 2018 · External reference

A rare occurrence of pulmonary alveolar proteinosis after lung transplantation

10.1055/s-0033-1348472 · 2013 · External reference

Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus

10.1093/ndt/gfq265 · 2010 · External reference

Lung transplant recipient with pulmonary alveolar proteinosis

2016 · External reference

The mechanism of action of FK-506 and cyclosporin A

10.1111/j.1749-6632.1993.tb17137.x · 1993 · External reference

FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA

1992 · External reference

Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta

10.1124/jpet.109.155838 · 2009 · External reference

Azithromycin alters macrophage phenotype

10.1093/jac/dkn007 · 2008 · External reference

Pulmonary alveolar proteinosis after lung transplantation

10.1002/rcr2.566 · 2020 · External reference